Study | N affected/ N evaluated patients | Specification |
---|---|---|
Treatment-related mortality | ||
Bui-Nguyen et al21 | 1/38 | Treatment-related leukaemia death 2 years after HSCT |
Cook et al26 | 2/36 | NR |
Doros et al41 | 1/1 | NR |
Engelhardt et al42 | 3/24 | Sepsis (N=2); pneumonia related to lung metastases (N=1) |
Kasper et al43 | 1/14 | Cardiac arrest of unknown cause |
Matsuzaki et al44 | 1/1 | Multiple organ failure |
Navid et al45 | 1/2 | Liver as well as kidney failure |
Philippe-Chomette et al27 | 1/14 | Died of treatment toxicity 12 months after HSCT |
Saab et al46 | 2/4 | Acute myocardial infarction (N=1); veno-occlusive disease (N=1) |
Slease et al47 | 2/3 | Progressive encephalopathy (N=1); sepsis (N=1) |
Total | 15/137 |
HSCT, autologous haematopoietic stem cell transplantation following high-dose chemotherapy; N, number; NR, not reported.